- Company Overview for SHIRE BIOTECH UK HOLDINGS LIMITED (10945403)
- Filing history for SHIRE BIOTECH UK HOLDINGS LIMITED (10945403)
- People for SHIRE BIOTECH UK HOLDINGS LIMITED (10945403)
- More for SHIRE BIOTECH UK HOLDINGS LIMITED (10945403)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
05 Feb 2019 | PSC02 | Notification of Takeda Pharmaceutical Company Limited as a person with significant control on 8 January 2019 | |
05 Feb 2019 | PSC07 | Cessation of Shire Plc as a person with significant control on 8 January 2019 | |
04 Sep 2018 | CS01 | Confirmation statement made on 3 September 2018 with updates | |
05 Jul 2018 | AP01 | Appointment of Mr Nicholas Hugh Meryon Insall as a director on 30 June 2018 | |
05 Jul 2018 | TM01 | Termination of appointment of Jonathan Ivan William Webb as a director on 30 June 2018 | |
14 Mar 2018 | TM02 | Termination of appointment of Oliver Strawbridge as a secretary on 1 March 2018 | |
14 Mar 2018 | AP04 | Appointment of Shire Corporate Services Limited as a secretary on 1 March 2018 | |
10 Nov 2017 | PSC07 | Cessation of Shire Pharmaceuticals International Unlimited Company as a person with significant control on 4 September 2017 | |
07 Nov 2017 | SH01 |
Statement of capital following an allotment of shares on 27 October 2017
|
|
15 Sep 2017 | AA01 | Current accounting period extended from 30 September 2018 to 31 December 2018 | |
15 Sep 2017 | PSC02 | Notification of Shire Plc as a person with significant control on 4 September 2017 | |
04 Sep 2017 | NEWINC |
Incorporation
Statement of capital on 2017-09-04
|